In the CPP group, 13 patients completed GnRHa stimulation tests, and 4 patients were diagnosed with CPP based on elevated LH and oestradiol (E2), uterine enlargement, and multiple follicles. The gene discussed is PLOD1; the disease is central precocious puberty.